KRISTEN FREGOSO: Open Payments
NPI 1730639451 · NORTH CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 24 payments from 10 companies in 2025. Trend: 2023 $284 · 2024 $593 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| PFIZER INC. | 2 | $33 |
| Abbott Laboratories | 1 | $20 |
| Corcept Therapeutics | 1 | $16 |
| Viatris Specialty LLC | 1 | $14 |
Products named: MOUNJARO, Ozempic, Kerendia, BREZTRI, OTEZLA, JARDIANCE, CARDIOMEMS, PREVNAR 20.
Industry payments across IL — which companies pay providers there.
